Detalles de la búsqueda
1.
Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine.
J Infect Dis
; 226(11): 1943-1948, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662415
2.
The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.
J Infect Dis
; 224(7): 1139-1146, 2021 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32103273
3.
Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination.
J Infect Dis
; 224(12): 2025-2034, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502272
4.
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.
Rheumatology (Oxford)
; 60(3): 1226-1233, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32910152
5.
Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.
BMC Infect Dis
; 14: 425, 2014 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25078387
6.
Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults.
Vaccine
; 40(19): 2714-2722, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35367070
7.
Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients.
Vaccine
; 39(1): 6-10, 2021 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33277059
8.
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Drug Saf
; 44(12): 1341-1353, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34622421
9.
EVT-701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti-tumor activity in models of solid cancers.
Pharmacol Res Perspect
; 9(5): e00854, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478236
10.
Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults.
J Gerontol A Biol Sci Med Sci
; 76(3): 485-490, 2021 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32530462
11.
CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
J Clin Invest
; 117(4): 1096-106, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17404623
12.
Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials.
Hum Vaccin Immunother
; 16(11): 2628-2633, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347767
13.
Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine.
Vaccine
; 38(18): 3489-3500, 2020 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31818534
14.
Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation.
Am J Kidney Dis
; 54(3): 522-32, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19520469
15.
The how's and what's of vaccine reactogenicity.
NPJ Vaccines
; 4: 39, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583123
16.
Adjuvant Systems for vaccines: 13â¯years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood.
Vaccine
; 37(38): 5670-5680, 2019 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420171
17.
Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
Vaccine
; 37(14): 2004-2015, 2019 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30850240
18.
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.
Hum Vaccin Immunother
; 15(12): 2865-2872, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216205
19.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50â¯years of age: A randomized trial.
Vaccine
; 36(29): 4278-4286, 2018 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29903674
20.
Erratum: Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity.
NPJ Vaccines
; 3: 13, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29582861